Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Hepatitis B stories

Oct 20, 2026

FDA approves GSK's hepatitis B drug Hibsago

The FDA approved GSK's hepatitis B drug Hibsago, allowing patients with the liver infection to maintain viral control after stopping long-term treatment. The approval offers a new treatment option for chronic hepatitis B patients.

Oct 20, 2026·2 sources
00
Sep 30, 2026

Infections caused 2.3 million cancer cases globally in 2024, study finds

The International Agency for Research on Cancer reported that infections were responsible for 2.3 million new cancer cases in 2024, representing 12% of all global cancer diagnoses. Helicobacter pylori, HPV, hepatitis B and C, and Epstein-Barr virus were the primary infectious causes.

Sep 30, 2026·3 sources
00
May 28, 2026

GSK's Experimental Hepatitis B Drug Achieves Functional Cure in Nearly 1 in 5 Patients in Late-Stage Trials

GSK reported that its experimental chronic hepatitis B drug helped nearly one in five patients achieve a functional cure in late-stage studies, vastly outpacing current treatments and raising hopes for a finite treatment course as an alternative to lifelong therapy.

May 28, 2026·2 sources
00
Apr 28, 2026

Delayed Hepatitis B Vaccination at Birth Increases Infant Infection Risk, Studies Show

Multiple new studies project that delaying hepatitis B vaccination after birth—as recommended in new U.S. policy that offers the vaccine only to at-risk infants—will lead to increased infections, decreased survival rates, and lifelong health complications among newborns.

Apr 28, 2026·3 sources
00

Top claims

  • ▪Prescribing warnings for Hibsago include risks of deteriorating kidney function, serious inflammatory adverse reactions such as vasculitis, and complications from improper injection
  • ▪Patients using Hibsago require regular blood tests during therapy to monitor for hepatic flares, reduced platelet counts, and kidney function risks
  • ▪Hibsago has secured regulatory approval in Japan and is under regulatory review by health authorities in China and Europe

Topics

Antiviral therapyDrug Policy, Pricing & ApprovalPharmaceutical IndustryFDA regulatory approvalChronic disease managementFDA drug approvalInfectious diseaseHepatitis B treatmentDrug Approval and Clinical TrialsOutbreak monitoring & surveillanceGlobal healthPreventive medicineClinical Trial Design & EvaluationInfectious Disease and OutbreaksDrug developmentClinical evaluationVaccines and Immunization PolicyChildhood vaccine policyVaccine access and deliveryChildhood vaccine policyPublic healthcareChildhood vaccine policyChildhood vaccine policyPublic health policy

Related entities

Epstein-Barr virusPublic health surveillanceGeriatric medicineUnited States